# Beatson West of Scotland Cancer Centre / CRUK Scotland Institute

Source: https://onco.cc/institutions/beatson-glasgow/  
OnCo record `beatson-glasgow` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Scotland's largest cancer centre, named after the surgeon who first used endocrine therapy for breast cancer, next to a leading cancer biology institute.

## Summary

The Beatson West of Scotland Cancer Centre at Gartnavel is the tertiary oncology centre for the west of Scotland and one of the largest in the UK. It takes its name from Sir George Beatson, who in 1896 reported that removing the ovaries could shrink advanced breast cancer, the first endocrine therapy. The adjacent Cancer Research UK Scotland Institute (formerly the Beatson Institute, founded 1967) under Owen Sansom is known for genetically engineered mouse models of colorectal and pancreatic cancer, cancer metabolism and cell death research, and the University of Glasgow's Wolfson Wohl Cancer Research Centre hosts Andrew Biankin's Precision-Panc programme for pancreatic cancer. Patients have access to a large radiotherapy service, early-phase trials and Scotland's molecular pathology network.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: The Beatson; Cancer Research UK Beatson Institute; Beatson Institute for Cancer Research
- City: Glasgow, GB
- Type: cancer-center
- Website: https://www.beatson.scot.nhs.uk

## Sources

- Beatson West of Scotland Cancer Centre: https://www.beatson.scot.nhs.uk
- CRUK Scotland Institute: https://www.beatson.gla.ac.uk
- Precision-Panc: https://www.precisionpanc.org

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- fronts: [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/), [Hormonal Therapy](https://onco.cc/fronts/hormonal/)
- technologies: [Comprehensive genomic profiling](https://onco.cc/technologies/cgp/), [Endocrine therapy (SERMs, AIs, SERDs)](https://onco.cc/technologies/endocrine-therapy/), [KRAS & RAS inhibitors](https://onco.cc/technologies/kras-inhibitors/), [Patient-derived xenografts](https://onco.cc/technologies/pdx-models/)
- targets: [Estrogen receptor (ERα)](https://onco.cc/targets/estrogen-receptor/), [KRAS](https://onco.cc/targets/kras/)
- institutions: [AMMF, the Cholangiocarcinoma Charity](https://onco.cc/institutions/ammf/), [ANCHOR Centre, Aberdeen Royal Infirmary](https://onco.cc/institutions/anchor-centre-aberdeen/), [Cancer Research UK](https://onco.cc/institutions/cruk/), [Edinburgh Cancer Centre / CRUK Scotland Centre](https://onco.cc/institutions/edinburgh-cancer-centre/), [Glasgow Royal Infirmary](https://onco.cc/institutions/glasgow-royal-infirmary/), [Wolfson Wohl Cancer Research Centre, University of Glasgow](https://onco.cc/institutions/wolfson-wohl-cancer-research-centre/)
- trials: [Precision-Panc](https://onco.cc/trials/precision-panc/), [SCOT](https://onco.cc/trials/scot/)
- people: [Owen Sansom](https://onco.cc/people/owen-sansom/), [Sharon Armstrong](https://onco.cc/people/sharon-armstrong/)
- key papers: [Genomic analyses identify molecular subtypes of pancreatic cancer](https://onco.cc/key-papers/paper-bailey-molecular-subtypes-pancreatic-nature-2016/)

---
JSON: https://onco.cc/api/v1/entities/beatson-glasgow.json